Effects of Delayed-Release Dimethyl Fumarate (DMF) on Health-Related Quality of Life in Patients With Relapsing-Remitting Multiple Sclerosis: An Integrated Analysis of the Phase 3 DEFINE and CONFIRM Studies.
Kita M, Fox RJ, Gold R, Giovannoni G, Phillips TJ, Sarda SP, Kong J, Viglietta V, Sheikh SI, Okwuokenye M, et al.